Revenue
|
Operating profit
|
Profit before tax
|
Profit for the year
|
Profit attributable to owners of the parent
|
Basic earnings per share
| |
(JPY Million)
|
(JPY Million)
|
(JPY Million)
|
(JPY Million)
|
(JPY Million)
|
(JPY)
| |
Previous Forecast (A)
|
25,273
|
5,991
|
4,143
|
2,174
|
1,703
|
35.86
|
Revised Forecast (B)
|
26,267
|
7,280
|
6,430
|
4,351
|
2,005
|
42.20
|
Difference (B-A)
|
994
|
1,289
|
2,287
|
2,177
|
302
|
-
|
Difference in ratio (%)
|
3.9%
|
21.5%
|
55.2%
|
100.1%
|
17.7%
|
-
|
(Reference) 2022 Actual
|
17,418
|
1,377
|
767
|
(868)
|
388
|
8.19
|
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Catalyst Biosciences Inc. published this content on 06 November 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 November 2023 11:12:43 UTC.